Variables | Crude | 95% CI | p-value | Adjusted | 95% CI | p-value |
---|---|---|---|---|---|---|
HR | HR | |||||
ESRD vs Non-ESRD | ||||||
Non-ESRD | 1.00 | 1.00 | ||||
ESRD | 2.09 | (1.74–2.51) | <0.001 | 2.23 | (1.84–2.69) | <0.001 |
Gender | ||||||
Male | 1.00 | 1.00 | ||||
Female | 0.97 | (0.81–1.17) | 0.766 | 0.93 | (0.77–1.12) | 0.453 |
Age | ||||||
< 65 | 1.00 | 1.00 | ||||
≥ 65 | 1.04 | (0.87–1.24) | 0.692 | 1.12 | (0.92–1.36) | 0.283 |
Urbanized level | ||||||
1 (City) | 1.00 | 1.00 | ||||
2 | 1.03 | (0.82–1.29) | 0.799 | 1.03 | (0.82–1.29) | 0.829 |
3 | 1.22 | (0.93–1.60) | 0.155 | 1.23 | (0.93–1.62) | 0.145 |
4 (Village) | 1.37 | (1.01–1.87) | 0.046 | 1.40 | (1.02–1.93) | 0.039 |
Income (NTD, per month) | ||||||
0 | 1.00 | 1.00 | ||||
1–15,840 | 1.23 | (0.92–1.64) | 0.167 | 1.20 | (0.89–1.61) | 0.240 |
15,841–25,000 | 1.06 | (0.83–1.34) | 0.645 | 0.96 | (0.75–1.24) | 0.773 |
≥ 25,001 | 0.82 | (0.59–1.14) | 0.242 | 0.76 | (0.54–1.08) | 0.125 |
Comorbidities | ||||||
DM | 1.41 | (1.17–1.70) | <0.001 | 1.50 | (1.24–1.82) | <0.001 |
HTN | 1.57 | (1.07–2.31) | 0.020 | 1.57 | (1.06–2.31) | 0.025 |
Autoimmune | 1.06 | (0.74–1.53) | 0.750 | 1.07 | (0.74–1.54) | 0.732 |
Liver cirrhosis | 1.22 | (0.87–1.71) | 0.255 | 1.01 | (0.72–1.43) | 0.945 |
CAD | 0.97 | (0.81–1.16) | 0.751 | 0.79 | (0.65–0.95) | 0.014 |
CVA | 1.04 | (0.86–1.26) | 0.659 | 0.93 | (0.76–1.13) | 0.457 |
COPD | 0.90 | (0.72–1.12) | 0.323 | 0.88 | (0.70–1.11) | 0.291 |